Abstract
Objective: To compare the effect of combined nasal continuous positive airway pressure respiration combined with drugs on obstructive sleep apnea-hypopnea syndrome (OSAHS) in different conditions to further evaluate the clinical effect of OSAHS. 82 patients with OSAHS admitted to our hospital from January 2016 to December 2019 are selected and divided into 2 groups according to the severity of OSAHS disease. 52 patients with moderate OSAHS and 30 patients with severe OSAHS are treated with nasal-continuous positive airway pressure (CPAP) combined with pedomodorus and Monrothna. The sleep quality is evaluated before treatment and 3 months after treatment, and the average blood oxygen saturation at night and the longest hypopnea time is determined. Results show thatthe Pittsburgh sleep index score of patients in the severe OSAHS group before treatment is lower than that in the moderate OSAHS group, and the average blood oxygen saturation level at night is higher than that in the moderate OSAHS group. The longest hypoventilation time is shorter than that in the OSAHS group. The difference is statistically significant (P
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
